Day: February 1, 2024

Baker Hughes Declares Increased Quarterly Dividend

Baker Hughes Declares Increased Quarterly Dividend

HOUSTON and LONDON, Feb. 01, 2024 (GLOBE NEWSWIRE) — Baker Hughes (NASDAQ: BKR) announced today that the Baker Hughes Board of Directors declared an increased quarterly cash dividend of $0.21 per share of Class A common stock payable on Feb. 23, 2024, to holders of record on Feb. 13, 2024. In line with our stated goal to responsibly grow the dividend over time, the dividend increase reflects a 5% growth rate, or $0.01, over the previous quarter’s dividend and an 11% increase, or $0.02, compared to the same quarter last year. Baker Hughes expects to fund its quarterly cash dividend from cash generated from operations. About Baker Hughes:Baker Hughes (NASDAQ: BKR) is an energy technology company that provides solutions to energy and industrial customers worldwide. Built on a century of experience and conducting business in over 120...

Continue reading

Post Holdings Reports Results for the First Quarter of Fiscal Year 2024; Raises Fiscal Year 2024 Outlook

Post Holdings Reports Results for the First Quarter of Fiscal Year 2024; Raises Fiscal Year 2024 Outlook

ST. LOUIS, Feb. 01, 2024 (GLOBE NEWSWIRE) — Post Holdings, Inc. (NYSE:POST), a consumer packaged goods holding company, today reported results for the first fiscal quarter ended December 31, 2023. Highlights: First quarter net sales of $2.0 billion Operating profit of $209.3 million; net earnings of $88.1 million and Adjusted EBITDA (non-GAAP)* of $359.5 million Raised fiscal year 2024 Adjusted EBITDA (non-GAAP)* outlook to $1,290-$1,340 million *For additional information regarding non-GAAP measures, such as Adjusted EBITDA, Adjusted net earnings, Adjusted diluted earnings per common share and segment Adjusted EBITDA, see the related explanations presented under “Use of Non-GAAP Measures” later in this release. Post provides Adjusted EBITDA guidance only on a non-GAAP basis and does not provide a reconciliation of its forward-looking...

Continue reading

TC Transcontinental Printing to Close its Saint-Hyacinthe Plant

TC Transcontinental Printing to Close its Saint-Hyacinthe Plant

MONTREAL, Feb. 01, 2024 (GLOBE NEWSWIRE) — TC Transcontinental (TSX: TCL.A TCL.B) announced today that it will gradually reduce operations at its printing plant in Saint-Hyacinthe (Québec), with a complete closure scheduled in April 2024. Its activities will gradually be transferred to other plants of the TC Transcontinental Printing network, mainly to the plant located in the Anjou borough of Montréal. “With the end of Publisac announced on November 3 and its gradual replacement by raddarTM, printed at our Anjou plant, we regretfully had to make the decision to close our Saint-Hyacinthe plant,” said Pierre Deslongchamps, Senior Vice President, Retail, Newspapers, Distribution, Magazines, Books and Catalogues, TC Transcontinental Printing. “Closing a plant we’ve operated since acquiring it in 1979 is a difficult decision, and we...

Continue reading

Crown Realty Partners Expands Portfolio With Acquisition of Atrium Building in Mississauga

Crown Realty Partners Expands Portfolio With Acquisition of Atrium Building in Mississauga

Crown Acquires Sheridan Exchange Crown Realty Partners (“Crown”) is pleased to announce the acquisition of a two-building complex comprised of 158,000 square feet located in south Mississauga. TORONTO, Feb. 01, 2024 (GLOBE NEWSWIRE) — Crown Realty Partners (“Crown”) is pleased to announce the acquisition of a two-building complex comprised of 158,000 square feet located in south Mississauga. The investment was made on behalf of Crown’s fifth value add fund, CR V LP. The complex, known as the Sheridan Exchange, is located at 2655 and 2695 North Sheridan Way, , benefits from easy access to the QEW Highway, excellent highway exposure, and nearby amenities which include dining options, hotels and entertainment facilities. The leasing and marketing program will capitalize on these attributes, together with the on-site amenities...

Continue reading

ARCA biopharma Announces 2023 Financial Results

ARCA biopharma Announces 2023 Financial Results

Company is currently engaged in a strategic review process, evaluating additional development of its assets, collaborations and other strategic options WESTMINSTER, Colo., Feb. 01, 2024 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today reported 2023 financial results and provided a corporate update. In April 2022, the Board of Directors established a Special Committee (the “Special Committee”) and, in May 2022, retained Ladenburg Thalmann & Co. Inc. (“Ladenburg”) to evaluate strategic options, including transactions involving a merger, sale of all or part of the Company’s assets, or other alternatives with the goal of maximizing stockholder value (the “Strategic Review”)....

Continue reading

Advisory: Fortis Inc. to Hold Teleconference and Webcast on February 9 to Discuss 2023 Annual Results

Advisory: Fortis Inc. to Hold Teleconference and Webcast on February 9 to Discuss 2023 Annual Results

ST. JOHN’S, Newfoundland and Labrador, Feb. 01, 2024 (GLOBE NEWSWIRE) — Fortis Inc. (“Fortis” or the “Corporation”) (TSX/NYSE: FTS) will release its 2023 financial results on Friday, February 9, 2024. A teleconference and webcast will be held the same day at 8:30 a.m. (Eastern) during which David Hutchens, President and Chief Executive Officer and Jocelyn Perry, Executive Vice President and Chief Financial Officer will discuss the Corporation’s 2023 annual financial results. Shareholders, analysts, members of the media and other interested parties are invited to listen to the teleconference via the live webcast on the Corporation’s website, https://www.fortisinc.com/investor-relations/events-and-presentations. Those members of the financial community in North America wishing to ask questions...

Continue reading

Clearfield Reports Fiscal First Quarter 2024 Results

Clearfield Reports Fiscal First Quarter 2024 Results

Repurchased approximately $12 million in shares under Share Repurchase Program, leaving $21 million available for additional repurchases. Announced a new product – a smaller vault which is designed to reduce deployment time and lower the cost of total deployment. Expects to achieve full Build America, Buy America (BABA) Act compliance by end of calendar 2024. MINNEAPOLIS, Feb. 01, 2024 (GLOBE NEWSWIRE) — Clearfield, Inc. (NASDAQ: CLFD), a leader in fiber connectivity, reported results for the fiscal first quarter 2024, ended December 31, 2023.   Fiscal Q1 2024 Financial Summary   (in millions except per share data and percentages) Q1 2024 vs. Q1 2023 Change  Change (%)     Net Sales $ 34.2     $ 85.9     $ (51.7 )   -60 %                   Gross Profit ($) $ 4.7     $ 30.6     $ (26.0 )   -85 %     Gross...

Continue reading

Arvinas to Present at 6th Annual Guggenheim Biotechnology Conference

Arvinas to Present at 6th Annual Guggenheim Biotechnology Conference

NEW HAVEN, Conn., Feb. 01, 2024 (GLOBE NEWSWIRE) — Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today announced that Ron Peck, M.D., Chief Medical Officer, and Randy Teel, Ph.D., Senior Vice President, Corporate and Business Development will participate in a fireside chat at the 6th Annual Guggenheim Biotechnology Conference on Wednesday, February 7 at 10:30 a.m. ET in New York. A live audio webcast of the presentation will be available here and under “Events and Presentations” of the Investors and Media section of the Company’s website. About ArvinasArvinas is a clinical-stage biotechnology company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development,...

Continue reading

Gray and Marquee Broadcasting Swap Television Station Assets

Gray and Marquee Broadcasting Swap Television Station Assets

ATLANTA, Feb. 01, 2024 (GLOBE NEWSWIRE) — Gray Television, Inc. (“Gray” or the “Company”) (NYSE: GTN) announced today that it has reached agreements with Marquee Broadcasting, Inc. (“Marquee”) to swap television stations. Gray will sell its television stations in the Cheyenne-Scottsbluff and Casper television markets (DMAs 194 and 198, respectively) to Marquee in exchange for Marquee’s FCC permit authorizing the construction of new, unbuilt television station KCBU in the Salt Lake City market (DMA 27). Neither party will pay additional cash or consideration to fulfill the terms of this swap. The transactions are expected to close simultaneously in the second quarter of 2024 following receipt of regulatory and other approvals. “Marquee is excited to acquire Gray’s leading stations in Wyoming and Western Nebraska. We are looking...

Continue reading

GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 

GeneDx to Report Fourth Quarter 2023 Financial Results on Tuesday, February 20, 2024 

STAMFORD, Conn., Feb. 01, 2024 (GLOBE NEWSWIRE) — GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic and clinical insights, today announced it will release financial results for the fourth quarter of 2023 after the market closes on Tuesday, February 20, 2024. Management will host a conference call that day to discuss 2023 financial and operating results and share full year 2024 guidance at 4:30 p.m. Eastern Time.  Conference Call Details Investors interested in listening to the conference call are required to register online. A live and archived webcast of the event will be available on the “Events” section of the GeneDx investor relations website at https://ir.genedx.com/.  About GeneDx GeneDx (Nasdaq: WGS) delivers personalized and actionable health insights to inform diagnosis, direct treatment...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.